Contact this trialFirst, we need to learn more about you.
Alkylating Agent
Busulfan +2 More for Prolymphocytic Leukemia
Recruiting1 awardPhase 1
Columbus, Ohio
This trial is studying a combination of romidepsin, fludarabine, and busulfan to see if it can help control leukemia or lymphoma. Researchers also want to learn the highest tolerable dose of romidepsin that can be given with this combination.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.